Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even ...

Shares of drugmaker Bristol Myers Squibb were up almost 6% as of Wednesday afternoon, despite a delay in a late-stage study ...

Bristol-Myers Squibb shares gained after the company announced that it will enroll additional patients in the ADEPT-2 study.

Brian’s Angels Homeless Outreach, a day program in Bristol, provides hot meals, clean clothing, showers and a safe space for ...

There was traffic chaos around Bristol this morning as several busy roads were blocked after crashes. One crash involved three cars and another route was blocked after a bus left the road. Areas that ...

Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with ...

The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year.

Bristol Myers Squibb will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer's disease.

Police are continuing to investigate the incident and are seeking any information or video footage pertaining to the crash.

Police were called to the area of Battle Street at James P. Casey Road around 9:37 p.m. Friday for a report of a vehicle ...

Coronary Microvascular Dysfunction is a conditioned that often causes chest pains due to disrupted blood flow.